Schwannoma Clinical Trials

6 recruiting

Schwannoma Trials at a Glance

21 actively recruiting trials for schwannoma are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Baltimore, Bologna, and Beijing. Lead sponsors running schwannoma studies include Christoph Arnoldner, Centre Hospitalier Universitaire de Besancon, and Albert Torrents Torrero.

Browse schwannoma trials by phase

Treatments under study

About Schwannoma Clinical Trials

Looking for clinical trials for Schwannoma? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Schwannoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Schwannoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 2

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Pain, ChronicSchwannomatosisSchwannomas
Massachusetts General Hospital40 enrolled1 locationNCT05684692
Recruiting
Phase 1Phase 2

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Vestibular Schwannoma
Akouos, Inc.27 enrolled4 locationsNCT06517888
Recruiting
Not Applicable

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

Vestibular Schwannoma
Medical College of Wisconsin36 enrolled1 locationNCT05702749
Recruiting
Not Applicable

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

SchwannomaIntracranial NeoplasmGrade I Meningioma+4 more
Emory University70 enrolled1 locationNCT04278118
Recruiting
Not Applicable

Evaluation of the CONVIVO System

Brain MetastasesGlioblastomaMeningioma+3 more
Dartmouth-Hitchcock Medical Center30 enrolled1 locationNCT05139277
Recruiting
Not Applicable

Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma

Vestibular SchwannomaVestibular Schwannomas
Albert Torrents Torrero75 enrolled1 locationNCT07364955
Recruiting
Not Applicable

StableEyes With Active Neurofeedback

Vestibular DisorderVestibular SchwannomaSpace Motion Sickness
Johns Hopkins University48 enrolled2 locationsNCT05622344
Recruiting

Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis

Gastrointestinal Stromal Tumor (GIST)SchwannomaSubmucosal Tumor+1 more
Huazhong University of Science and Technology130 enrolled1 locationNCT07078136
Recruiting
Not Applicable

Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit

Vestibular SchwannomaUnilateral Vestibular Deficit
Hospices Civils de Lyon26 enrolled1 locationNCT06660082
Recruiting
Not Applicable

CI Following VS Removal or Labyrinthectomy

Vestibular SchwannomaMeniere Disease
Ohio State University15 enrolled1 locationNCT03795675
Recruiting

Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma

Quality of Life OutcomesAcoustic Schwannoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna40 enrolled1 locationNCT06844461
Recruiting

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

OtotoxicityVestibular Schwannoma
University Hospital, Geneva258 enrolled1 locationNCT05641441
Recruiting

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

MeningiomaSchwannomaBrain Tumor, Primary+2 more
Seoul National University Hospital3,000 enrolled1 locationNCT05254197
Recruiting

Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study

Hearing LossVestibular Schwannoma
Christoph Arnoldner8 enrolled1 locationNCT03745534
Recruiting

Intraoperative EABR for Decision Making

Hearing LossVestibular Schwannoma
Christoph Arnoldner15 enrolled1 locationNCT03745560
Recruiting
Not Applicable

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

Vestibular SchwannomaNeurinoma, AcousticAcoustic Neuroma
Centre Hospitalier Universitaire de Besancon20 enrolled1 locationNCT06112509
Recruiting
Not Applicable

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Vestibular SchwannomaGlioma, Astrocytic
Northern Care Alliance NHS Foundation Trust17 enrolled1 locationNCT06572475
Recruiting
Not Applicable

Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma

Vestibular Schwannoma
University Hospital, Toulouse50 enrolled1 locationNCT04859335
Recruiting

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

MeningiomaGliomaPrimary Brain Tumor+1 more
Jona Hattangadi-Gluth250 enrolled1 locationNCT05576103
Recruiting

Establishing Prospective Mediastinal Tumor Database of PUMCH

Germ Cell TumorLymphomaThymic Epithelial Tumor+4 more
Peking Union Medical College Hospital2,000 enrolled1 locationNCT06421805